Skip to main contentAI and Advanced
/
CAMLINFINE · NSEMarket ticker unavailable · configure an authorised index feed
CA
NSE · Equity shares · Chemical Manufacturing-1.00 · -1.01%
Camlin Fine Sciences CAMLINFINE
NSE:INR 98
BSE:INR 121.95
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for CAMLINFINE
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 99
Day rangeINR 97.1 — INR 100.99
52-week rangeINR 96.21 — INR 235
Volume3.79 L
Market cap2,388.8
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,723.31
Net Income (INR Cr)27.63
Rev Growth (5 Year %)7.74
Book Value40.53
EPS-0.97
Price/BV2.42Computed
Research path: Interpret Camlin Fine Sciences's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
CAMLINFINECamlin Fine Sciences1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 2,323.9 | 2,023.79 | 1,951.72 |
| Cash Equivalents | 153.22 | 35.82 | Not available |
| Other Liabilities Total | 7.76 | 6.05 | 5.78 |
| Long Term Debt | 302.61 | 268.3 | 332.72 |
| Common Stock Total | 19.21 | 18.79 | 16.75 |
| Other Current Assets Total | 148.68 | 60.15 | 19.38 |
| Total Assets | 2,323.9 | 2,023.79 | 1,951.72 |
| Current Portof LT Debt/Capital Leases | 383.08 | 116.86 | 99.69 |
| Total Equity | 1,040.88 | 901.67 | 864.75 |
| Long Term Investments | 48.62 | 25.13 | 7.88 |
| Retained Earnings(Accumulated Deficit) | 1,021.67 | 130.55 | 259.58 |
| Total Common Shares Outstanding | 19.21 | 18.79 | 17.14 |
| Tangible Book Valueper Share Common Eq | 40.53 | 44.91 | 46.96 |
| Goodwill Net | 233.41 | 47.47 | 47.08 |
| Total Liabilities | 1,283.02 | 1,122.11 | 1,086.97 |
| Total Debt | 720.09 | 681.3 | 683.03 |
| Short Term Investments | 57.83 | 39.27 | 0.97 |
| Cashand Short Term Investments | 211.05 | 143.34 | 81.23 |
| Total Receivables Net | 373.02 | 422.06 | 365.56 |
| Deferred Income Tax | 3.91 | 3.31 | 6.84 |
| Accounts Receivable-Trade Net | 373.02 | 328.22 | 285.15 |
| Property/Plant/Equipment Total-Net | 657.94 | 653.63 | 802.33 |
| Minority Interest | -40.07 | -26.89 | -7.8 |
| Total Current Liabilities | 974.42 | 846.21 | 732.27 |
| Total Inventory | 503.74 | 543.34 | 526.23 |
| Accounts Payable | 505.19 | 377.22 | 324.64 |
| Other Currentliabilities Total | 86.14 | 70.05 | 64.9 |
| Total Long Term Debt | 337.01 | 293.44 | 349.88 |
| Intangibles Net | 28.87 | 10.23 | 12.81 |
| Other Long Term Assets Total | 93.41 | 98.7 | 76.12 |
| Note Receivable-Long Term | 25.16 | 5.24 | 4.84 |
| Total Current Assets | 1,236.49 | 1,183.39 | 1,000.67 |
| Capital Lease Obligations | 34.4 | 25.14 | 17.16 |
| Accumulated Depreciation Total | Not available | -543.55 | -334.01 |
| Accrued Expenses | Not available | 11.08 | 9.58 |
| Other Equity Total | Not available | 40.92 | 53.29 |
| Prepaid Expenses | Not available | 14.5 | 8.27 |
| Additional Paid-In Capital | Not available | 711.41 | 490.22 |
| Cash | Not available | 68.25 | 80.25 |
| Property/Plant/Equipment Total-Gross | Not available | 1,187.46 | 1,090.77 |
| Notes Payable/Short Term Debt | Not available | 271 | 233.46 |
| Unrealized Gain(Loss) | Not available | 0 | 44.91 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %5.54
Margins
Operating Margin 12m-0.16
Operating Margin 5y Avg6.6
Net Profit Margin 12m-2.11
Net Profit Margin 5y2.36
Yield
Dividend Yield %0
Valuation
Price to Sale Ratio1.39
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk63.07
Analyst consensus
ConsensusBuy
Consensus score2.50
Analyst opinions2
Strong Sell count0
Sell count0
Hold count1
Buy count1
Strong Buy count0
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,680 | 2.57 L | 58.09 | — |
| Solar Industries India | INR 18,880.05 | 1.71 L | 99.61 | — |
| Pidilite Industries | INR 1,574.3 | 1.60 L | 64.76 | — |
| SRF | INR 2,866.25 | 85,204.75 | 44.57 | — |
| Linde India | INR 6,895 | 58,803.47 | 110.53 | — |
Shareholding
Ownership
- Promoter
- 48.03%
- FII
- 0.91%
- MF
- 5.12%
- Other
- 45.94%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Camlin Fine Sciences files BRSR for FY 2025-26 - scanx.tradeMarket news · 18 Jul 2026, 5:01 pm
Camlin Fine Sciences files BRSR for FY 2025-26 scanx.trade
Camlin Fine Sciences Reports ₹23.54 Cr Profit Amidst Revenue Growth and EBITDA Drop - WhalesbookMarket news · 18 Jul 2026, 4:24 pm
Camlin Fine Sciences Reports ₹23.54 Cr Profit Amidst Revenue Growth and EBITDA Drop Whalesbook
Camlin Fine Sciences schedules 33rd AGM for August 11 - scanx.tradeMarket news · 15 Jul 2026, 12:28 pm
Camlin Fine Sciences schedules 33rd AGM for August 11 scanx.trade
Camlin Fine Sciences Ltd is Rated Strong Sell - MarketsMojoMarket news · 10 Jul 2026, 10:23 am
Camlin Fine Sciences Ltd is Rated Strong Sell MarketsMojo
Vinpai: Camlin Fine Sciences Holds 95.41% of Capital After Its Simplified Tender Offer, No Mandatory Squeeze-Out - Idéal InvestisseurMarket news · 9 Jul 2026, 2:03 pm
Vinpai: Camlin Fine Sciences Holds 95.41% of Capital After Its Simplified Tender Offer, No Mandatory Squeeze-Out Idéal Investisseur
Camlin Fine Sciences Discloses Resignation of Senior R&D Executive - The Globe and MailMarket news · 9 Jul 2026, 2:53 am
Camlin Fine Sciences Discloses Resignation of Senior R&D Executive The Globe and Mail
Corporate actions
Events
- annual General MeetingAGM
- board MeetingsAudited Results
- annual General MeetingPOM
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsPreferential Issue of shares
Rusaka Markets Community
Discussion and sentiment for Camlin Fine Sciences
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Camlin Fine Sciences Limited is an India-based specialty chemicals company, which is engaged in the research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company's products portfolio is categorized into shelf-life solutions, performance chemicals, aroma ingredients, and health and wellness. Its products include catechol, tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Ascorbyl Palmitate (ASP), 4-Tertiary Butyl Catechol, Xtendra, Guaiacol, Para DiMethoxy Benzene, NaSure, Hydroquinone, and Veratrole. Its aroma ingredients mainly include Vanillin, Ethyl Vanillin, and Natural Vanillin. The Company's products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care. Its brands include Ezential, Nasure, adorr, Dinamics, Xtendra, and Biosus.
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- CAMLINFINE
- BSE Code
- 532834
Questions
Stock FAQ
What is the symbol and ISIN of Camlin Fine Sciences?
Camlin Fine Sciences has the symbol CAMLINFINE and ISIN - INE052I01032.
What is the current price of Camlin Fine Sciences?
Camlin Fine Sciences is currently trading at INR 98.00.
What are the year high and year low of Camlin Fine Sciences?
Camlin Fine Sciences has a year high of INR 235.00 and a year low of INR 96.21.
What is the market capitalization of Camlin Fine Sciences?
Camlin Fine Sciences has a market capitalization of INR 2,388.80 crore.
What is the P/E ratio of Camlin Fine Sciences?
Camlin Fine Sciences has a P/E ratio of NA.
What is the dividend yield of Camlin Fine Sciences?
Camlin Fine Sciences has a dividend yield of 0.00%.
How is the financial performance of Camlin Fine Sciences based on revenue, net income, and EPS?
Camlin Fine Sciences has revenue of INR 1,723.31 crore, net income of INR 27.63 crore, and EPS of INR -1.28.
What is the book value of Camlin Fine Sciences?
Camlin Fine Sciences has a book value of INR 40.53.
What is the debt-to-equity ratio of Camlin Fine Sciences?
Camlin Fine Sciences has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Camlin Fine Sciences?
Camlin Fine Sciences has a price-to-book ratio of 2.42 and a price-to-sales ratio of 1.39.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.